Specifically, SCARB2 expression was correlated with immune subtypes (C3 inflammatory, C4 lymphocyte depleted and C5 immunologically quiet) (Figure 8A) in LGG but not related to any immune subtypes in GBM (Figure 8C). The gene discussed is SCARB2; the disease is glioblastoma.